There are various treatment options for osteoarthritis, depending on the severity of the symptoms. In some cases, surgery is necessary, such as the placement of a hip or knee prosthesis. However, not everyone is satisfied with the result: 15–20% of patients with a knee prosthesis continue to have complaints, and 5–8% even regret the procedure. Sometimes surgery is unavoidable, but as long as that moment has not yet arrived, there are other possibilities.
At JointCare Clinics, we focus on the treatment of osteoarthritis with injection therapies
BioleVox™ HA One is an innovative injectable hyaluronic acid with a high molecular weight (3Mda), specially developed for effective and long-lasting relief of osteoarthritis symptoms. With one of the highest concentrations of sodium hyaluronate on the market (120 mg / 4.8 mL), BioleVox™ HA One offers a unique solution for joint conditions.
Why choose BioleVox™ HA One?
Arthrosamid is a unique injectable gel, consisting of 2.5% polyacrylamide, specifically developed to effectively and long-lastingly relieve knee complaints. The gel permanently integrates with the synovial tissue in the knee (the inner lining), making this tissue thicker, stronger, and more flexible.
How does Arthrosamid work?
Long-lasting results:
With just one injection, Arthrosamid provides a therapeutic effect that lasts for at least 5 years, making it an ideal solution for patients looking for an effective, non-surgical treatment for knee complaints.
Arthrosamid is a good option when a patient no longer benefits from one of the other injection treatments.
WINT is an advanced PRP treatment specifically developed to address the osteoarthritis process by blocking the WNT signaling pathway in the body. This WNT pathway plays a key role in the onset and progression of osteoarthritis.
In the WINT treatment, the patient’s blood is used to filter PRP (Platelet Rich Plasma) and enrich it with a high concentration of the DKK-1 protein. This protein acts as a natural counterpart to WNT and helps to slow down the osteoarthritis process. As a result, pain complaints decrease and joint function improves.
Results of WINT:
The Xerthra™ PRP is an innovative and advanced platelet separation system, developed for preparing platelet-rich plasma (PRP) with unparalleled precision. This system produces a PRP solution with an exceptionally high concentration of platelets, up to nine times higher than in untreated plasma.
Why Choose Xerthra™ PRP?
Kiomedine-One is an injectable hydrogel with carboxymethyl-chitosan, a natural product derived from mushrooms. This gel is the solution for when other non-operative injections such as hyaluronic acid and PRP/ACP do not help. The gel improves the lubrication of the synovial fluid, reduces friction, binds to free radicals, and protects the joint against oxidative stress. This reduces inflammation, pain, and swelling in knee osteoarthritis. It also works for patella-related pain complaints that are very difficult to treat. The therapeutic effect lasts approximately 16 months.
